Before the use of corticosteroids, the visual prognosis of SO was generally considered to be poor. The aggressive use of corticosteroids in combination with immunosuppressive therapy has improved the visual prognosis. However, the relapsing nature of the disease demands careful long-term follow-up to prevent serious complications associated with recurrences.
It is interesting to analyze a few studies which stated prognostic factors based on histopathological findings. Lubin et al reported a direct correlation between the severity of inflammation in the exciting eye and the final visual acuity of the sympathizing eye.[10] However, Winter[19] and Reynard et al[18] observed no direct correlation.
Makley and Azar[17]reported on the long-term follow-up of patients with SO in 1978. In their series, they observed that relapses and complications such as secondary glaucoma, cataract, exudative retinal detachment, and choroidal scarring were common among patients with SO. Many …